Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 929.00
-17.00 (-1.80%)
Sep 28, 2026, 3:29 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 11.15 billion as of September 28, 2026. Its market cap has increased by 25.82% in one year.
Market Cap
11.15B
Enterprise Value
11.24B
Revenue
8.54B
Ranking
n/a
PE Ratio
30.14
Stock Price
929.00
ChartMarket Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 11.15B, an increase of 321.19%. That is a compound annual growth rate of 53.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 11.15B | 36.18% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 16.19B |
| Infinium Pharmachem | 4.08B |
| Quest Laboratories | 1.48B |
| Sotac Pharmaceuticals | 995.05M |
| Zenith Drugs | 761.41M |
| Vilin Bio Med | 729.59M |
| Medicamen Organics | 282.56M |
| Sunrest Lifescience | 171.22M |